We are live on ! Find out more
ABMD

Abiomed Inc

Delisted

ABMD was delisted on the 21st of December, 2022.

8 hedge funds and large institutions have $4.62M invested in Abiomed Inc in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 499 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 6

98% less funds holding

Funds holding: 5178 (-509)

99% less call options, than puts

Call options by funds: $437K | Put options by funds: $45.7M

100% less capital invested

Capital invested by funds: $10.5B → $4.62M (-$10.5B)

100% less funds holding in top 10

Funds holding in top 10: 30 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 499

Holders
8
Holders Change
-509
Holders Change %
-98.45%
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
1
Reduced
6
Closed
499
Calls
$437K
Puts
$45.7M
Net Calls
-$45.2M
Net Calls Change
-$79.7M
Name Holding Trade Value Shares
Change
Change in
Stake
SOADOR
126
State of Alaska Department of Revenue
Alaska
-$4.88M -19,852 Closed
Treasurer of the State of North Carolina
127
Treasurer of the State of North Carolina
North Carolina
-$4.85M -19,759 Closed
Toronto Dominion Bank
128
Toronto Dominion Bank
Ontario, Canada
-$4.75M -19,360 Closed
BPC
129
Banque Pictet & Cie
Switzerland
-$4.74M -19,284 Closed
Squarepoint
130
Squarepoint
New York
-$4.61M -18,763 Closed
IMRF
131
Illinois Municipal Retirement Fund
Illinois
-$4.51M -18,362 Closed
FCM
132
Frontier Capital Management
Massachusetts
-$4.25M -17,312 Closed
LWCFA
133
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
-$3.85M -15,692 Closed
Retirement Systems of Alabama
134
Retirement Systems of Alabama
Alabama
-$3.71M -15,101 Closed
AAM
135
Autus Asset Management
Arizona
-$3.7M -15,072 Closed
TD Asset Management
136
TD Asset Management
Ontario, Canada
-$3.72M -14,957 Closed
Royal London Asset Management
137
Royal London Asset Management
United Kingdom
-$3.68M -14,950 Closed
Robeco Institutional Asset Management
138
Robeco Institutional Asset Management
Netherlands
-$3.62M -14,739 Closed
Osaic Holdings
139
Osaic Holdings
Arizona
-$3.49M -14,223 Closed
BNP Paribas Financial Markets
140
BNP Paribas Financial Markets
France
-$3.48M -14,165 Closed
WMSA
141
Weiss Multi-Strategy Advisers
New York
-$3.42M -13,900 Closed
MIM
142
MetLife Investment Management
New Jersey
-$3.39M -13,786 Closed
APG Asset Management
143
APG Asset Management
Netherlands
-$3.35M -13,365 Closed
SSA
144
Schonfeld Strategic Advisors
New York
-$3.27M -13,300 Closed
SAM
145
Storebrand Asset Management
Norway
-$3.26M -13,254 Closed
TI
146
Trexquant Investment
Connecticut
-$3.24M -13,178 Closed
UIM
147
USS Investment Management
United Kingdom
-$3.23M -13,129 Closed
HighTower Advisors
148
HighTower Advisors
Illinois
-$3.15M -13,014 Closed
SOMRS
149
State of Michigan Retirement System
Michigan
-$3.17M -12,914 Closed
AIG
150
American International Group
New York
-$3.16M -12,875 Closed

ABMD Hedge Fund Activity: Q4 2022 in Review

8 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q4 2022, worth a combined $4.62M — down 100% from $10.5B a quarter earlier.

Sellers outnumbered buyers: 499 funds closed out of ABMD and 0 opened new positions — a net loss of 499 holders — while 6 trimmed existing stakes and 1 added.

The largest buyer was Blue Trust Inc, adding an estimated $14K. The largest seller was Vanguard Group, exiting entirely with an estimated $1.29B sold.

  • 8 institutional investors held Abiomed Inc (ABMD) as of Q4 2022, down from 517 in Q3 2022.
  • Funds reported $4.62M of Abiomed Inc stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Abiomed Inc positions in Q4 2022 and 499 closed out, a net change of -499 holders.
  • The largest Abiomed Inc buyer in Q4 2022 was Blue Trust Inc, an estimated $14K added.
  • The largest Abiomed Inc seller in Q4 2022 was Vanguard Group, an estimated $1.29B sold.

Based on aggregated 13F filings for Q4 2022.